Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05520333 · ClinicalTrials.gov registry record · NA

Brief Intervention to Prevent Alcohol Socialization (BIPAS Alcohol)

A NA study, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
132
Enrollment target

NCT05520333: Completed NA study, sponsored by University of North Carolina, Chapel Hill.

NCT05520333 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 132 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05520333, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
132 participants
Enrollment target

Study Summary

Early alcohol socialization occurs within the family. This multi-level, high-reach, low-intensity intervention to prevent early alcohol use capitalizes on the influence of providers, immunization timing, and pediatric guidelines that advise healthcare providers to give anticipatory guidance about early alcohol use. In conjunction, the intervention capitalizes on the power of technology to reinforce and expand upon pediatrician messages. The study seeks to understand the feasibility and effectiveness of a pilot intervention designed to prevent alcohol socialization through education of parents of rising 6th grade students.

Primary Outcome

Parental Alcohol Socialization Beliefs, Attitudes, and Practices scale (eight items). A four-point scale ranging from "strongly disagree" (lowest value=1) to "strongly agree" (highest value=4) will be used, with higher values on the scale indicating a more pro-sipping belief system. The scores will have a range from 8-32. Higher values are associated with worse outcomes.

Interventions

  • BEHAVIORAL BIPAS Alcohol

Trial Details

FieldValue
Enrollment Target 132 participants
Start Date 2023-05-01
Est. Completion 2024-07-30
Phase NA

What the finished NCT05520333 record still lists

NCT05520333 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 1 intervention - of which BIPAS Alcohol is the first listed.

NCT05520333 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05520333 about?

NCT05520333 is a clinical study titled "Brief Intervention to Prevent Alcohol Socialization (BIPAS Alcohol)". Early alcohol socialization occurs within the family. This multi-level, high-reach, low-intensity intervention to prevent early alcohol use capitalizes on the influence of providers, immunization timing, and pediatric guidelines that advise healthcare providers to give anticipatory guidance about ea...

What is the current status of trial NCT05520333?

This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2023-05-01. Estimated completion is 2024-07-30.

What interventions are being tested in trial NCT05520333?

The interventions under investigation include: BIPAS Alcohol (BEHAVIORAL).

Who is sponsoring clinical trial NCT05520333?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05520333's enrollment target sits among peer trials

132 729th of 2000 higher than 1,269 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01766297 · 132 participants · Phase 2

    Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

  • NCT04002947 · 132 participants · Phase 2

    Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma

  • NCT04128189 · 132 participants · Phase 3

    Shingrix in Renal Transplant Recipients

  • NCT04199780 · 132 participants · NA

    Effects of tDCS Combined With CBI on Postsurgical Pain

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05520333, the US trial registry maintained by the National Library of Medicine. NCT05520333 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.